Abeona therapeutics to present at jefferies gene therapy/editing summit

New york and cleveland, oct. 21, 2021 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today announced that vish seshadri, ph.d., m.b.a., chief executive officer of abeona, is scheduled to present at the jefferies gene therapy/editing summit on wednesday, october 27, 2021, at 3:30 p.m. et.
ABEO Ratings Summary
ABEO Quant Ranking